Pharmaceuticals in China
| Publication Date | December 2007 |
|---|---|
| Publisher | Datamonitor |
| Product Type | Report |
| Pages | 33 |
| ISBN Number | not applicable |
| Product Code | DAT03035 |
Summary
The Pharmaceuticals in China industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.
Scope
- Contains an executive summary and data on value, volume and/or segmentation
- Provides textual analysis of the industry's recent performance and future prospects
- Incorporates in-depth five forces competitive environment analysis and scorecards
- Includes a five-year forecast of the industry
- The leading companies are profiled with supporting key financial metrics
- Supported by the key macroeconomic and demographic data affecting the market
Highlights
- Detailed information is included on market size, measured by value and/or volume
- Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
- Market shares are covered by manufacturer or brand
Why you should buy this report
- Spot future trends and developments
- Inform your business decisions
- Add weight to presentations and marketing materials
- Save time carrying out entry-level research
Market Definition
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2006 annual average exchange rates.
For the purpose of this report Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.
Content
- Executive Summary
- Chapter 1 Market Overview
- 1.1 Market Definition
- 1.2 Research Highlights
- 1.3 Market Analysis
- Chapter 2 Market Value
- Chapter 3 Market Segmentation I
- Chapter 4 Market Segmentation Ii
- Chapter 5 Market Share
- Chapter 6 Five Forces Analysis
- 6.1 Summary
- 6.2 Buyer Power
- 6.3 Supplier Power
- 6.4 New Entrants
- 6.5 Substitutes
- 6.6 Rivalry
- Chapter 7 Leading Companies
- 7.1 Jiangsu Yangtze River Pharmaceutical Group
- 7.2 Pfizer Inc
- 7.3 Astrazeneca Plc
- 7.4 Roche Holding Ltd
- Chapter 8 Market Forecasts
- 8.1 Market Value Forecast
- Chapter 9 Macroeconomic Indicators
- Chapter 10 Appendix
- 10.1 Methodology
- 10.2 Industry Associations
- 10.3 Related Datamonitor Research
- List Of Tables
- Table 1: China Pharmaceuticals Market Value: $ Million, 2003-2007
- Table 2: China Pharmaceuticals Market Segmentation I: % Share, By Value, 2007
- Table 3: China Pharmaceuticals Market Segmentation Ii: % Share, By Value, 2007
- Table 4: China Pharmaceuticals Market Share: % Share, By Value, 2007
- Table 5: Key Facts: Jiangsu Yangtze River Pharmaceutical Group
- Table 6: Key Facts: Pfizer Inc
- Table 7: Key Financials: Pfizer Inc
- Table 8: Key Facts: Astrazeneca Plc
- Table 9: Key Financials: Astrazeneca Plc
- Table 10: Key Facts: Roche Holding Ltd
- Table 11: Key Financials: Roche Holding Ltd
- Table 12: China Pharmaceuticals Market Value Forecast: $ Million, 2007-2012
- Table 13: China Size Of Population (Million) , 2003-2007
- Table 14: China Gdp (Constant 2000 Prices, $ Billion), 2003-2007
- Table 15: China Inflation, 2003-2007
- Table 16: China Exchange Rate, 2003
About this Product
Delivery Details
PDF:Delivered by email usually within 4 to 8 UK business hours.
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















